Zobrazeno 1 - 10
of 3 481
pro vyhledávání: '"Linagliptin"'
Autor:
Aljohani H; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia. hialjehani@gmail.com., Alrubaish FS; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Alghamdi WM; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Al-Harbi F; Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Jul; Vol. 58 (4), pp. 622-633. Date of Electronic Publication: 2024 Apr 18.
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome.
Autor:
Ge M; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Molina J; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Tamayo I; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Zhang G; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Kim JJ; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Njeim R; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Fontanesi F; Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida., Pieper MP; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Merscher S; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Sharma K; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Fornoni A; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida.
Publikováno v:
Kidney360 [Kidney360] 2024 Jul 01; Vol. 5 (7), pp. 1002-1011. Date of Electronic Publication: 2024 May 23.
Autor:
Esaifan HA; Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan., Saadah LM; Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan., Abu Hammour K; Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan., Abu Farha RK; Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Publikováno v:
PloS one [PLoS One] 2024 Aug 26; Vol. 19 (8), pp. e0309365. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).
Autor:
Tsuji S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Kudo U; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Hatakeyama R; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Shoda K; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan., Nakamura S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Shimazawa M; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan. Electronic address: shimazawa@gifu-pu.ac.jp.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Jun 04; Vol. 711, pp. 149897. Date of Electronic Publication: 2024 Apr 09.
Autor:
Estrella MY; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico.; Metabolic Research Laboratory, Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico., Daniel NR; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Maestría en Ciencias Bioquímicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico., Armando ED; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico., Cristian PM; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico., Aarón VJ; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico., Paul SJ; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Maestría en Ciencias Bioquímicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico., David GV; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Maestría en Ciencias Bioquímicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico., Cristian MO; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico.; Programa de Maestría en Ciencias Bioquímicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico., de Lourdes RM; Metabolic Research Laboratory, Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico., Lola EM; Endocrinology Department Hospital Regional de Alta Especialidad del Bajío, León, Mexico., Alberto AG; Endocrinology Department Hospital Regional de Alta Especialidad del Bajío, León, Mexico., Osbaldo RA; Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico. oresendis@inmegen.gob.mx.; Coordinación de la Investigación Científica - Red de Apoyo a la Investigación - Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico. oresendis@inmegen.gob.mx., Rodolfo GM; Metabolic Research Laboratory, Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico. rguardado@ugto.mx.
Publikováno v:
Scientific reports [Sci Rep] 2024 Apr 27; Vol. 14 (1), pp. 9678. Date of Electronic Publication: 2024 Apr 27.
Autor:
Günes-Altan M; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Bosch A; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Striepe K; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Bramlage P; Institute for Pharmacology and Preventive Medicine, Bahnhofstraße 20, 49661, Cloppenburg, Germany., Schiffer M; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Schmieder RE; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany. roland.schmieder@uk-erlangen.de., Kannenkeril D; Department of Nephrology and Hypertension, University Hospital Erlangen Friedrich-Alexander University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Publikováno v:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 May 29; Vol. 23 (1), pp. 184. Date of Electronic Publication: 2024 May 29.
Autor:
Aref H; Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.; Medicinal Chemistry Department, Faculty of Pharmacy, El Menoufia University, El Menoufia, Shebin El Kom 32511, Egypt., Hammad S; Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31511, Egypt., Darwish KM; Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt., Elgawish MS; Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.; Chemistry Department, Korea University, Seoul 02841, Korea Republic.
Publikováno v:
Chemical research in toxicology [Chem Res Toxicol] 2024 May 20; Vol. 37 (5), pp. 779-790. Date of Electronic Publication: 2024 Apr 29.
Autor:
Nady ME; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt., El-Raouf OMA; Pharmacology Department, Egyptian Drug Authority (EDA), formerly known as National Organization for Drug Control and Research (NODCAR), 6 Abou Hazem St., Pyramids Ave, Giza, Egypt., El-Sayed EM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. elsayed200_1956@azhar.edu.eg.
Publikováno v:
Molecular biology reports [Mol Biol Rep] 2024 May 05; Vol. 51 (1), pp. 608. Date of Electronic Publication: 2024 May 05.
Autor:
Karve T; Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA., Banga AK; Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. Electronic address: banga_ak@mercer.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Apr 10; Vol. 654, pp. 123992. Date of Electronic Publication: 2024 Mar 11.
Autor:
Nady ME; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University., Abd El-Raouf OM; Pharmacology Department, Egyptian Drug Authority (EDA), formerly known as National Organization for Drug Control and Research (NODCAR)., El-Sayed EM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University.
Publikováno v:
Biological & pharmaceutical bulletin [Biol Pharm Bull] 2024; Vol. 47 (5), pp. 1008-1020.